Source link : https://www.newshealth.biz/health-news/il-6-receptor-inhibitors-show-early-promise-for-cppd/
Interleukin 6 receptor (IL-6r) inhibition is a promising approach for the treatment of calcium pyrophosphate deposition disease (CPPD), although no prospective studies have been conducted to date. Nevertheless, a retrospective analysis of patients treated with the IL-6r inhibitor tocilizumab, presented at American College of Rheumatology (ACR) 2024 Annual Meeting, showed improved CPPD control in more […]
Author : News Health
Publish date : 2024-12-20 12:47:02
Copyright for syndicated content belongs to the linked Source.